2nd Annual Gene Therapy Analytical Development Summit USA - digital event

In the context of rapid gene therapy progress and mounting regulatory scrutiny, the 2nd Annual Gene Therapy Analytical Development Summit will virtually unite large pharma and innovative biotechs to discuss the full and comprehensive range of analytical tools required to guarantee the consistency, quality and safety of gene therapy products.

On Day One (December 1) our CEO, Ales Strancar's will present:

9:15 am EST | Empty-full AAV ratio assay using multi detectors HPLC